China Resources Pharmaceutical Group Limited's latest marketcap:
As of 06/16/2025, China Resources Pharmaceutical Group Limited's market capitalization has reached $4.24 B. According to our data, China Resources Pharmaceutical Group Limited is the 3661th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | $4.24 B |
| Revenue (ttm) | $34.92 B |
| Net Income (ttm) | $451.43 M |
| Shares Out | 6.28 B |
| EPS (ttm) | $0.07 |
| Forward PE | 7.93 |
| Ex-Dividend Date | 05/28/2025 |
| Earnings Date | 08/25/2025 |
China Resources Pharmaceutical Group Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/16/2025 | HK$4.24 B | -7.02% | 3661 |
| 12/31/2024 | HK$35.81 B | 11.11% | 3194 |
| 12/29/2023 | HK$32.23 B | -18.83% | 3350 |
| 12/30/2022 | HK$39.71 B | 78.03% | 2662 |
| 12/31/2021 | HK$22.3 B | -10.8% | 4886 |
| 12/31/2020 | HK$25 B | -44.97% | 3938 |
| 12/31/2019 | HK$45.44 B | -29.26% | 2119 |
| 12/31/2018 | HK$64.23 B | 0.99% | 1360 |
| 12/29/2017 | HK$63.6 B | 15.66% | 1556 |
| 12/30/2016 | HK$54.99 B | 1405 |
Company Profile
About China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited is an investment holding company specializing in the research, development, manufacturing, distribution, and retail of pharmaceutical and healthcare products. Headquartered in Wan Chai, Hong Kong, the company operates primarily in Mainland China and internationally.
Business Segments
- Pharmaceutical Manufacturing – Produces chemical drugs, Chinese medicines, and healthcare products.
- Pharmaceutical Distribution – Provides supply chain solutions, warehousing, and logistics services.
- Pharmaceutical Retail – Operates retail pharmacies under brands like CR Care and Teck Soon Hong.
- Others – Includes property holding and additional healthcare-related services.
Product Offerings
The company supplies a wide range of pharmaceutical and healthcare products, including treatments for:
- Cardiovascular and cerebrovascular conditions
- Alimentary tract and metabolism disorders
- Respiratory and orthopedic ailments
- Oncology and medical nutrition solutions
- Pediatrics, dermatology, and anti-infective medications
Distribution & Services
China Resources Pharmaceutical Group distributes its products to hospitals, medical institutions, and retail pharmacies. The company also offers value-added pharmaceutical supply chain services to manufacturers and dispensers.
Corporate Background
Originally named China Resources Medications Group Limited, the company rebranded to its current name in December 2011. Established in 2007, it operates as a subsidiary of CRH (Pharmaceutical) Limited.
Frequently Asked Questions
-
What is China Resources Pharmaceutical Group Limited's (HKG-3320) current market cap?As of 06/16/2025, China Resources Pharmaceutical Group Limited (including the parent company, if applicable) has an estimated market capitalization of $4.24 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does China Resources Pharmaceutical Group Limited (HKG-3320) rank globally by market cap?China Resources Pharmaceutical Group Limited global market capitalization ranking is approximately 3661 as of 06/16/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.